Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Recruiting2
Terminated1

Clinical Trials (3)

Showing 3 of 3 trials
NCT05573997Recruiting

Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure

NCT05791916Recruiting

Novel Biomarkers in Patients With Acute Myocardial Infarction

NCT03890146TerminatedPrimary

Concordance of Capillary Blood Biological Samples With Conventional Venousbiological Blood Samples.

Showing all 3 trials

Research Network

Activity Timeline